Kuban DA - Search Results

1

Racial influence on biochemical disease-free survival in men treated with external-beam radiotherapy for localized prostate cancer.

Rosser CJ, Kuban DA, Lee SJ, Levy LB, Pettaway C, Kamat AM, Chichakli R, Lee A, Cheung RM, Sanchez-Ortiz R, Pisters LL. Rosser CJ, et al. Among authors: kuban da. J Natl Med Assoc. 2004 Jul;96(7):939-44. J Natl Med Assoc. 2004. PMID: 15253325 Free PMC article.

2

The durability of external beam radiation therapy for prostate cancer: can it be identified?

Davis JW, Kolm P, Wright GL Jr, Kuban D, El-Mahdi A, Schellhammer PF. Davis JW, et al. J Urol. 1999 Sep;162(3 Pt 1):758-61. doi: 10.1097/00005392-199909010-00036. J Urol. 1999. PMID: 10458360

3

Fifteen-year minimum follow-up of a prostate brachytherapy series: comparing the past with the present.

Schellhammer PF, Moriarty R, Bostwick D, Kuban D. Schellhammer PF, et al. Urology. 2000 Sep 1;56(3):436-9. doi: 10.1016/s0090-4295(00)00711-1. Urology. 2000. PMID: 10962309

4

Intrafraction prostate motion during IMRT for prostate cancer.

Huang E, Dong L, Chandra A, Kuban DA, Rosen II, Evans A, Pollack A. Huang E, et al. Among authors: kuban da. Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):261-8. doi: 10.1016/s0360-3016(02)02738-4. Int J Radiat Oncol Biol Phys. 2002. PMID: 12023128

5

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial.

Pollack A, Zagars GK, Starkschall G, Antolak JA, Lee JJ, Huang E, von Eschenbach AC, Kuban DA, Rosen I. Pollack A, et al. Among authors: kuban da. Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1097-105. doi: 10.1016/s0360-3016(02)02829-8. Int J Radiat Oncol Biol Phys. 2002. PMID: 12128107 Clinical Trial.

6

Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with external beam radiation.

Rosser CJ, Chichakli R, Levy LB, Kuban DA, Smith LG, Pisters LL. Rosser CJ, et al. Among authors: kuban da. J Urol. 2002 Aug;168(2):536-41. J Urol. 2002. PMID: 12131304

7

Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial.

Pollack A, Zagars GK, Antolak JA, Kuban DA, Rosen II. Pollack A, et al. Among authors: kuban da. Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):677-85. doi: 10.1016/s0360-3016(02)02977-2. Int J Radiat Oncol Biol Phys. 2002. PMID: 12377318 Clinical Trial.

8

Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancer.

Rosser CJ, Kuban DA, Levy LB, Chichakli R, Pollack A, Lee AK, Pisters LL. Rosser CJ, et al. Among authors: kuban da. J Urol. 2002 Nov;168(5):2001-5. doi: 10.1016/S0022-5347(05)64282-6. J Urol. 2002. PMID: 12394695

9

Stage T1c prostate cancer: a heterogeneous category with widely varying prognosis.

Hung AY, Levy L, Kuban DA. Hung AY, et al. Among authors: kuban da. Cancer J. 2002 Nov-Dec;8(6):440-4. doi: 10.1097/00130404-200211000-00007. Cancer J. 2002. PMID: 12500852

10

Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinoma.

Rosser CJ, Reyes AO, Vakar-Lopez F, Levy LB, Kuban DA, Hoover DC, Lee AK, Pisters LL. Rosser CJ, et al. Among authors: kuban da. Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):1-6. doi: 10.1016/s0360-3016(02)04468-1. Int J Radiat Oncol Biol Phys. 2003. PMID: 12694817

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

223 results

Search Page

Filters